These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35053580)

  • 1. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?
    Shimamura T; Goto R; Watanabe M; Kawamura N; Takada Y
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
    Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
    J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.
    Elshamy M; Aucejo F; Menon KV; Eghtesad B
    World J Hepatol; 2016 Jul; 8(21):874-80. PubMed ID: 27478537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience.
    Ju MR; Yopp AC
    Ann Gastroenterol Surg; 2020 May; 4(3):208-215. PubMed ID: 32490334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
    Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
    Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review.
    Toniutto P; Fumolo E; Fornasiere E; Bitetto D
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
    Mehta N; Dodge JL; Grab JD; Yao FY
    Hepatology; 2020 Mar; 71(3):943-954. PubMed ID: 31344273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
    Akbulut S; Koc C
    J Gastrointest Cancer; 2020 Dec; 51(4):1107-1113. PubMed ID: 32857265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: when is liver transplantation oncologically futile?
    Viveiros A; Zoller H; Finkenstedt A
    Transl Gastroenterol Hepatol; 2017; 2():63. PubMed ID: 28815223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
    Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
    Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
    Hameed B; Mehta N; Sapisochin G; Roberts JP; Yao FY
    Liver Transpl; 2014 Aug; 20(8):945-51. PubMed ID: 24797281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
    Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.
    Cillo U; Giuliani T; Polacco M; Herrero Manley LM; Crivellari G; Vitale A
    World J Gastroenterol; 2016 Jan; 22(1):232-52. PubMed ID: 26755873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
    Hong G; Suh KS; Suh SW; Yoo T; Kim H; Park MS; Choi Y; Paeng JC; Yi NJ; Lee KW
    J Hepatol; 2016 Apr; 64(4):852-9. PubMed ID: 26658686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma.
    Rudnick SR; Russo MW
    Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):265-275. PubMed ID: 29231769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?
    Strassburg CP
    Visc Med; 2016 Aug; 32(4):263-271. PubMed ID: 27722163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma.
    Meischl T; Rasoul-Rockenschaub S; Győri G; Scheiner B; Trauner M; Soliman T; Berlakovich G; Pinter M
    United European Gastroenterol J; 2021 Mar; 9(2):209-219. PubMed ID: 32741316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.
    Takada Y; Tohyama T; Watanabe J
    J Hepatobiliary Pancreat Sci; 2015 Apr; 22(4):279-86. PubMed ID: 25408520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.